Rein Therapeutics, Inc. (RNTX) analyst actions

Rating and price-target actions on RNTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RNTX overview →

1 measured RNTX analyst action event.

DateHeadlineEvent5-minTo close
Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPFPress release+0.00%+1.12%
Get an email when RNTX moves on news →
Keep exploring

More RNTX: earnings → · SEC filings → · RNTX overview →